{"id":432908,"title":"Post-Authorization Requirements - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-02","captureTimestamp":"2026-01-02T09:09:57.578000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/clinical-trials/post-authorization-requirements.html","snippet":"Post-Authorization Requirements Once an application has received regulatory authorization, the sponsor is required to inform Health Canada of the following: Clinical Trial Site Information If clinical trial site information was not available at the time of application, a…","rawSnapshotUrl":"/api/snapshots/raw/432908","browseUrl":"https://replay.healtharchive.ca/job-6/20260102090957/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/clinical-trials/post-authorization-requirements.html#ha_snapshot=432908","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}